Trial intelligence / Profile preview

Evaluation of Microwave Ablation Using Starwave System for Small Liver Malignancies

NCT06426992Recruiting

Sponsor
Seoul National University Hospital
Start
Apr 2024
Primary completion
Aug 2026
Countries
1
01

Overview

Open-label, single-arm trial in liver cancer, sponsored by Seoul National University Hospital. Primary endpoints: Technical Success Rate at 0 weeks and Local Tumor Recurrence Rate at 12 months. Started Apr 2024; status: recruiting.

02

Conditions

liver cancer

Beyond the preview

Go deeper on NCT06426992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06426992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call